Cargando…
Empirical Use of Dopaminergic Agents for Restless Legs Syndrome Could be Associated With a Risk of Iatrogenic Parkinson’s Disease
Autor principal: | Sugit, Yasuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808268/ https://www.ncbi.nlm.nih.gov/pubmed/24171062 http://dx.doi.org/10.4021/jocmr1583w |
Ejemplares similares
-
Migraine with aura and restless legs syndrome
por: Larner, Andrew J.
Publicado: (2007) -
Restless Legs Syndrome and Leg Motor Restlessness in Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2015) -
Restless legs syndrome in patients with Crohn’s disease
por: Katsanos, Aristeidis H., et al.
Publicado: (2013) -
Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease
por: Nuermaimaiti, Maierdanjiang, et al.
Publicado: (2018) -
Treatment of restless legs syndrome/Willis-Ekbom disease with selenium
por: Ulfberg, Jan, et al.
Publicado: (2016)